Anti-CD25 rhMAb
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Anti-CD25 rhMAb, covering 2024-04-15 to 2025-08-08. Get the full timeline:
Most recent: Clinical Trial Update: Anti-CD25 rhMAb for aGVHD Prevention in High-Risk Adults Using the daGOAT Model [Phase 2]